0001562180-15-000420.txt : 20150529 0001562180-15-000420.hdr.sgml : 20150529 20150529180844 ACCESSION NUMBER: 0001562180-15-000420 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20150528 FILED AS OF DATE: 20150529 DATE AS OF CHANGE: 20150529 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Sage Therapeutics, Inc. CENTRAL INDEX KEY: 0001597553 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 215 FIRST STREET CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: 617-299-8380 MAIL ADDRESS: STREET 1: 215 FIRST STREET CITY: CAMBRIDGE STATE: MA ZIP: 02142 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: STARR KEVIN P CENTRAL INDEX KEY: 0001192603 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36544 FILM NUMBER: 15900776 MAIL ADDRESS: STREET 1: 75 SIDNEY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 4 1 primarydocument.xml PRIMARY DOCUMENT X0306 4 2015-05-28 false 0001597553 Sage Therapeutics, Inc. SAGE 0001192603 STARR KEVIN P C/O SAGE THERAPEUTICS, INC. 215 FIRST STREET CAMBRIDGE MA 02142 true false true false Stock Options (Right to buy) 73.13 2015-05-28 4 A false 13922.00 73.13 A 2025-05-28 Common Stock 13922.00 13922.00 D The stock option award was issued pursuant to the Sage Therapeutics, Inc., 2014 Stock Option and Incentive Plan. The option shall vest in full on May 28, 2016 , subject to continued service through such date. /s/ Laurie Burlingame, as Attorney-in-Fact for Kevin P. Starr 2015-05-29